Technology | Remote Monitoring | June 08, 2016

Wearable Monitor Allows Hospitals Improved Heart Failure Post-discharge Care

System combines wearable biosensor with mobile device-based monitoring to improve patient care post-discharge

Vital Connect, BePATIENT, BeVITAL remote monitoring system, HealthPatch MD

Vital Connect's HealthPatch MD wearable sensor, part of the BeVITAL remote monitoring system.

June 8, 2016 — Vital Connect Inc., developer of wearable biosensor technologies, and BePATIENT, a startup that develops patient-centric digital health solutions, announce the first North American deployment of BeVITAL. The remote patient monitoring solution combines VitalConnect’s U.S. Food and Drug Administration (FDA)-cleared biosensor, HealthPatch MD, with BePATIENT’s web-based solution and associated app, which allows the implementation of personalized healthcare programs accessible through mobile devices and computers.

This spring, BeVITAL will be used in a post-discharge heart failure patient monitoring study at John Muir Medical Center in Walnut Creek and Concord, Calif. Neal White, M.D., heart failure director at John Muir said, “We’re looking forward to seeing how sensor technology and connected patients combine to improve heart failure outcomes for our patients, including reduced readmissions.” The BeVITAL Solution will also be used to follow patients returning home after outpatient surgical procedures at Hospital Infantile De Las Californias in Tijuana, Mexico, in a study run by Scripps Translational Science Institute in San Diego.

The BeVITAL solution can be used to monitor and transmit eight FDA- and CE-cleared biometric data streams from HealthPatch MD directly to practitioners’ smartphones, tablets or computers. In addition, the BeVITAL Solution provides individualized care plans to patients along with meaningful insights to clinicians and researchers.

BeVITAL has already facilitated the post-discharge monitoring of over 80 surgical patients in clinical studies at five hospitals in Europe with two more deployments scheduled for this summer. Phillipe Topart, M.D., a surgeon from the Clinique de l’Anjou in France said, “BeVITAL appears to be a pioneering, innovative solution allowing us to meet the requirements of bariatric surgery follow-up. In general surgery, the vital signs monitoring HealthPatch MD along with the BePATIENT mobile app is a unique tool for remote patient monitoring and detecting post-operative complications. This solution represents a major support tool in complex ambulatory surgery. It seems to me that BeVITAL is a leading connected health solution.”

A patient-centric solution, BeVITAL has been positively received by patients. One patient reported, “The BeVITAL solution gave me the confidence I needed to leave the hospital earlier as I knew my medical team was remotely monitoring my health. It was really easy to use and help me understand what I needed to do after my surgery”.

For more information: www.bepatient.com

Related Content

Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Biotronik Home Monitoring implanted EP device remote wireless monitoring system
News | May 24, 2017
May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces th
Consumers Warned About Accuracy of Heart Rate Apps in New Study
News | Mobile Devices| May 22, 2017
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability
Apple Watch used for tracking patient arrhythmias using an artificial intelligence-based algorithm

Researchers are using the Apple Watch heart rate monitor app to track patient arrhythmias using an artificial intelligence-based algorithm. 

Feature | Wearable Sensors| May 11, 2017
May 11, 2017 — A new study shows that the Apple Watch's heart rate sensor, when paired with an artificial intelligenc
wearable defibrillators prevent sudden cardiac death in pediatric patients
Feature | Sudden Cardiac Arrest| May 11, 2017
May 11, 2017 — A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in
Spok Survey Confirms Mobile Device Infrastructure Improvements and Diversity in Hospitals
News | Mobile Devices| May 03, 2017
Spok Inc. recently released the second part of the company's annual mobility in healthcare survey. Spok has been...
Assessing Heart Disease Risk Within Arm's Reach

This figure demonstrates the histological grading scale that was used in accordance with the American Heart Association (AHA) to assign grades of atherosclerosis. The purpose of this figure is to give criteria and explain why sections were assigned specific grades. Sections are stained in hematoxylin and eosin. Stars indicate the vessel lumen. Horizontal panels represent each grade observed in the study, I-VII (excluding VI). The vertical columns depict the same sections at different magnifications. Image courtesy of Christopher Hoehmann.

News | Cardiac Diagnostics| May 03, 2017
May 3, 2017 — A new study published in...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing| May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
Non-O Blood Groups Associated With Higher Risk of Heart Attack
News | Cardiac Diagnostics| May 01, 2017
Having a non-O blood group is associated with a higher risk of heart attack, according to research presented at Heart...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
Overlay Init